These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2736588)

  • 1. [Repeat screening for colorectal carcinoma in a population of asymptomatic individuals after 2 years].
    Zoubek V; Zoubková H
    Cas Lek Cesk; 1989 Apr; 128(15):463-4. PubMed ID: 2736588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of screening for colorectal carcinoma in the Bruntál District using the Haemoccult Test 1985-1986].
    Zoubek V; Zoubková H
    Cas Lek Cesk; 1989 Apr; 128(15):460-2. PubMed ID: 2736587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of screening for colorectal carcinoma in the District of Bruntál using the Haemoccult Test in 1985-1988.
    Zoubek V; Zoubková H
    Czech Med; 1990; 13(2-3):52-7. PubMed ID: 2245757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems in the early diagnosis and treatment of colorectal carcinoma and adenoma in the aged].
    Zoubek V; Zoubková H; Mrůzek M
    Vnitr Lek; 1990 Oct; 36(10):998-1001. PubMed ID: 2256262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with screening for colorectal carcinoma using the Haemoccult Test].
    Zoubek V; Zoubková H
    Cesk Zdrav; 1989 Mar; 37(3):117-21. PubMed ID: 2720834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
    Hofbauer F; Mach K; Egermann G
    Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Population screening for colorectal carcinoma by examining feces for occult hemorrhage].
    Musil D
    Vnitr Lek; 1999 Aug; 45(8):496-9. PubMed ID: 11045153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
    Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
    J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Costs and benefits of screening for colorectal tumors using the Hemoccult test in asymptomatic individuals 45-60 years of age].
    Fric P; Zoubek V; Dvoráková H; Roth Z
    Cas Lek Cesk; 1991 Mar; 130(12):370-3. PubMed ID: 1903329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for colorectal carcinoma in the region surrounding the city of Frýdek-Místek between 1999 - 2001].
    Urban O; Chalupa P; Reha J; Orhalmi J; Hájek A; Paiger K; Vasutová I; Garcic A; Bubeník B
    Vnitr Lek; 2002 Oct; 48(10):962-5. PubMed ID: 16737146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.
    Zhou DY; Feng FC; Zhang YL; Lai ZS; Zhang WD; Li LB; Xu GL; Wan TM; Pan DS; Zhou D
    Chin Med J (Engl); 1993 Oct; 106(10):739-42. PubMed ID: 8033605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
    Nakama H; Fukazawa K
    Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of colorectal carcinomas detected by mass screening].
    Kikkawa N; Tsuchiya Y; Matsui S; Murai M; Yamamoto H; Matsui K
    Gan No Rinsho; 1989 Jul; 35(8):923-6. PubMed ID: 2746866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
    Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
    Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal occult blood testing: comparative evaluation of a two-hole versus a three-hole single slide test.
    Porschen R; Kruis W; Strohmeyer G
    Hepatogastroenterology; 1993 Apr; 40(2):191-3. PubMed ID: 8509054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.